Can NLR, PLR, and LMR be used as prognostic indicators in patients with pulmonary embolism? Author's reply on commentary COMMENT

Yükleniyor...
Küçük Resim

Tarih

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Assoc Basic Medical Sci Federation Bosnia & Herzegovina Sarajevo

Erişim Hakkı

info:eu-repo/semantics/openAccess
Attribution 3.0 United States

Özet

We appreciate the comments made by Dr. Bedel et al. NLR, PLR, and LMR are affected by various diseases such as oncological, collagen tissue, inflammatory, or severe renal/liver diseases [1]. Due to this, we have listed some of the dis-orders mentioned above in the tables. Hematological diseases, collagen tissue disease, inflammatory diseases, congenital heart disease, or severe renal/liver disease were excluded from the study. However, the presence of malignancy did not affect our results in the regression analysis.

Açıklama

Yıldırım, Tarık (Balikesir Author)

Anahtar Kelimeler

Research & Experimental Medicine

Kaynak

Bosnian Journal of Basic Medical Sciences

WoS Q Değeri

Scopus Q Değeri

Cilt

21

Sayı

4

Künye

Onay

İnceleme

Ekleyen

Referans Veren

Creative Commons lisansı

Aksi belirtilmedikçe, bu öğenin lisansı şu şekilde tanımlanmıştır info:eu-repo/semantics/openAccess